The field of medical exoskeletons is evolving at a tremendous pace driven by rapid advancements in material science, biomedical engineering and robotics. Medical exoskeletons provide powered augmentation to help individuals with mobility challenges perform daily tasks by assisting or enhancing human movement and activity.
Growing need for medical exoskeletons
The global population is aging rapidly with over one billion people projected to be over the age of 65 by 2030. At the same time, diseases like strokes and spinal cord injuries leave thousands of people with reduced mobility every year. All this has created a huge latent need for rehabilitation technologies and devices that can augment human ability and help those with limited mobility regain independence.
Medical exoskeletons are emerging as a promising solution to address this need. They leverage cutting edge technologies to reduce the burden of disability and enhance quality of life for patients. Devices under development range from simple passive exoskeletons that provide mechanical support to advanced powered robotic systems that actively assist limb movements.
Current state of the technology
The earliest medical exoskeletons date back to the 1970s but only in the past decade have we seen significant advances. Notable milestones include the ReWalk system approved by FDA in 2014 to help paraplegics stand and walk. Other notable players like Ekso Bionics, Cyberdyne, Panasonic and Parker Hannifin are developing innovative exoskeleton technologies targeting different mobility challenges.
The current range of medical exoskeletons encompasses:
Passive exoskeletons that provide structural support for the body or limbs without any motor power. Examples include braces for spinal injuries.
Powered lower-limb exoskeletons that assist with walking. These use motors and sensors at hip and knee joints to power limb movement.
Upper limb exoskeletons that power arm, hand and finger movements to aid tasks like lifting objects.
Rehabilitation exoskeletons that provide controlled resistance to assist physical therapy and improve muscle strength over time.
Technological advances are also steering new use cases like exoskeletons tailored for elderly care to augment mobility and prevent falls. Lighter, low-cost designs are emerging for home rehabilitation.
Expanding commercial availability
While the technology is still Global Medical Exoskeleton maturing, commercial availability of medical exoskeletons is increasing. Major hospitals have started using devices like Ekso and ReWalk in rehab programs. Several stroke and spinal cord injury patients have benefitted from at-home exoskeleton therapy models.
Key markets leading the commercialization include the United States, Japan and Western European countries who are actively funding R&D initiatives. Initial adoption is focused on high-income individuals but costs are steadily declining to eventually penetrate broader markets worldwide.
Reimbursements from public and private insurers for using medical exoskeletons are another major factor influencing commercial growth. Positive clinical trial results demonstrating benefits like faster recovery and long-term independence will be pivotal in gaining wider insurance coverage.
Global demand for medical exoskeletons is projected to surge in the coming decade as the technology increases in capabilities and accessibility. The worldwide medical exoskeleton market size is estimated to reach $3 billion by 2030 according to recent reports, registering a CAGR of over 35% from 2020 levels.
Drivers of future progress
Significant progress is still needed to realize the full potential of medical exoskeletons in assisting mobility across diverse conditions and geographies. Key drivers that will shape further advancement include:
Materials innovation
Lighter, stronger and more flexible materials like carbon fiber composites, shape memory alloys and nanomaterials will make exoskeletons more durable, comfortable and affordable. Novel materials can better interface with the human body.
Control and sensing
Advanced sensors, controllers and soft robotics will enable exoskeletons to detect subtle user motions and precisely augment natural movements. Technologies like electromyography and brain-computer interfaces hold promise to achieve highly intuitive control.
Portability and customization
Miniaturization of components, batteries and integration of electronics will improve portability of medical exoskeletons for active daily use. 3D printing and modular designs will help customize devices based on an individual's anatomy, condition and needs.
Clinical evidence and guidelines
Large-scale clinical trials and real-world data on outcomes like activity, independence and quality of life metrics will validate therapeutic value. Standardized guidelines on assessment, prescription and training protocols will optimize usage.
Access and affordability
Mass production techniques, open-source development models, global partnerships and innovative financing options can potentially scale up access and drive down costs further to include low and middle income regions worldwide.
Conclusion
Medical exoskeleton technology holds immense potential to revolutionize rehabilitation and assistance for mobility challenges. Rapidly evolving capabilities combined with favorable demographic and economic conditions have set the stage for unprecedented growth and adoption worldwide. Concerted efforts across scientific, engineering, clinical and industrial domains can help realize this technology's full societal impact in enhancing lives and independence globally in the coming decades.
For more insights, read-https://www.newsstatix.com/global-medical-exoskeletons-trends-size-and-share-analysis/
Digital technology and healthcare IT solutions are radically changing medicine and public health. From research and development to new treatments, apps, platforms and wearables and having a profound impact.
With aging populations - the impact of age-related and chronic diseases, such as cancer and diabetes, is steadily on the rise. Waste also plays a big role in the ongoing need to find new solutions to serious challenges. In the U.S. alone, The Institute of Medicine estimates that $750 billion of medical spending is wasted every year (around 30% of health-care spending) "on unnecessary services, excessive administrative costs, fraud, and other problems."
As more and more people are suffering from chronic diseases and challenges created by a traditional treatment approach, proactive healthcare and related health tech solutions continue to gain traction as a viable alternative to traditional medicine.
